Is a delay in ALK inhibitor initiation associated with poorer survival? A retrospective analysis based on real-world data.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.15_suppl.e18240
Abstract: e18240 Background: The time between a patient’s positive biomarker test result and initiation of targeted therapy may vary due to a number of factors, including the use of chemotherapy prior to or after the biomarker… read more here.
Keywords: chemotherapy; chemotherapy prior; test result; initiation ... See more keywords